GLPwatch
Weekend therapy in diabetes.
J Pak Med Assoc · 2016
Last updated 2026-05-28Researchers are exploring diabetes drugs that can be taken just once a week, including injectable options like dulaglutide, exenatide QW, and semaglutide, as well as oral medications such as omarigliptin and trelagliptin. These drugs are either already available or in advanced stages of development for weekly use.
AI summary of the abstract below.
| Journal | J Pak Med Assoc, 2016 |
|---|---|
| Citations | 4 |
| Relative citation ratio | 0.13 |
| NIH percentile | 9 |
| Molecules | — |
| Conditions studied | Type 2 Diabetes |
Abstract
This article introduces the concept of "weekend therapy", which has now become reality in diabetes. It briefly describes injectable and oral drugs which are currently available, or are in advanced stages of development, for use in once weekly administration. These include dulaglutide, exenatide QW, semaglutide, omarigliptin and trelagliptin.
Verbatim abstract via PubMed 27183953 ↗